Skip to content

CRDL - Cardiol Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Cardiol Therapeutics Inc Class A

CRDL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CRDLCardiol Therapeutics Inc Class A

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $2.00
52-wk low: $0.88
Prev close: $1.46
Mkt cap: $229.0M
Beta: 0.47
P/S: 1014.9x

Smart money

7 funds hold a position.

Real smart money

Funds holding this stock

7 holders

Combined position$3.0M

CI
Citadel
Ken Griffin · Q2 2026 13F
$844K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in $0.05 a share above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $229M

Valuation

P/S1014.87
P/B12.81

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CRDL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $228.97M
Beta: 0.47

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

12.8x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-190.2%

$819K

position

TS

Two Sigma

Q2 2026 13F

$792K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for CRDL

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.04+$0.05

-$0.09 expected

Next report

What the street expects next

EPS expected

-$0.08

-$0.08 to -$0.08

Revenue expected

$0.00

3 analysts

Last 30 days

1up2down

Analysts cutting estimates

Estimate drift

+0.02

Change in 30 days

-190.2%

ROA-90.9%

Growth

Beta0.47